The team is creating AI products that revolutionize the reproductive medicine sector with the help of their software platforms EMBRYOAID and FOLLISCAN.
MIM Fertility has raised €1.8M across 1 funding round from 2 investors, most recently a Seed round in Dec 2023. Based in Ochota, Poland; active in AI. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-12-04 | Seed | €1.8M |
| Peleton,Tangent Line |
| View deal → |
